Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02837601 · ClinicalTrials.gov registry record · NA
Pneumoperitoneum Management With SurgiQuest AirSeal® at Low vs. Higher Pressure
A NA study, sponsored by Akron Children's Hospital.
- Not yet
- Registry status
- NA
- Development phase
- 102
- Enrollment target
NCT02837601 is a NA study that has not yet begun recruiting, run by Akron Children's Hospital. The registered enrollment target is 102 participants.
The verdict
NCT02837601, a NA study, has not yet begun recruiting, sponsored by Akron Children's Hospital.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
Study Summary
A prospective, randomized, controlled single-center clinical Study designed to evaluate Physician Preference related to the use of the SurgiQuest AirSeal® Insufflation System (AIS) at low vs. higher pressures for the Management of pneumoperitoneum. Subjects will be randomized in a 1:1 treatment device to control ratio into one of two (2) different study arms: 1. AIS with an insufflation pressure target of 9mmHg ±1mmHg; or 2. AIS with an insufflation pressure target of 15mmHg ±1mmHg.
Interventions
- DEVICE AirSeal® Insufflation System (AIS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2021-03 |
| Est. Completion | 2027-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02837601
The ClinicalTrials.gov registry entry for NCT02837601 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Akron Children's Hospital, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AirSeal® Insufflation System (AIS) is the first listed.
NCT02837601 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02837601 about?
NCT02837601 is a clinical study titled "Pneumoperitoneum Management With SurgiQuest AirSeal® at Low vs. Higher Pressure". A prospective, randomized, controlled single-center clinical Study designed to evaluate Physician Preference related to the use of the SurgiQuest AirSeal® Insufflation System (AIS) at low vs. higher pressures for the Management of pneumoperitoneum. Subjects will be randomized in a 1:1 treatment devi...
What is the current status of trial NCT02837601?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 102 participants. The study started on 2021-03. Estimated completion is 2027-11.
What interventions are being tested in trial NCT02837601?
The interventions under investigation include: AirSeal® Insufflation System (AIS) (DEVICE).
Who is sponsoring clinical trial NCT02837601?
This trial is sponsored by Akron Children's Hospital, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.